Wells Fargo & Company Alx Oncology Holdings Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Wells Fargo & Company holds 10,496 shares of ALXO stock, worth $14,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,496

Previous 10,575 0.75%

Holding current value

$14,799

Previous $63,000 69.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.81 - $8.13 $142 - $642	-79 Reduced 0.75%	10,496 $19,000
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $7,305 - $21,967	1,251 Added 13.42%	10,575 $63,000
Q1 2024 May 10, 2024	BUY	$10.95 - $16.79 $11,256 - $17,260	1,028 Added 12.39%	9,324 $103,000
Q4 2023 Feb 09, 2024	BUY	$4.81 - $15.38 $13,900 - $44,448	2,890 Added 53.46%	8,296 $123,000
Q3 2023 Nov 13, 2023	SELL	$4.19 - $7.35 $15,197 - $26,658	-3,627 Reduced 40.15%	5,406 $25,000
Q2 2023 Aug 15, 2023	BUY	$4.37 - $9.56 $17,165 - $37,551	3,928 Added 76.94%	9,033 $67,000
Q1 2023 May 12, 2023	BUY	$4.52 - $11.71 $14,974 - $38,795	3,313 Added 184.88%	5,105 $23,000
Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $8,996 - $12,250	946 Added 111.82%	1,792 $20,000
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $22,369 - $41,150	-2,718 Reduced 76.26%	846 $9,000
Q2 2022 Aug 12, 2022	SELL	$5.89 - $19.46 $40,576 - $134,059	-6,889 Reduced 65.9%	3,564 $29,000
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $55,678 - $89,982	-4,079 Reduced 28.07%	10,453 $177,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $173,252 - $599,812	8,062 Added 124.61%	14,532 $312,000
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $291,062 - $448,484	5,543 Added 597.95%	6,470 $478,000
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $1,044 - $1,504	20 Added 2.21%	927 $50,000
Q1 2021 May 13, 2021	SELL	$62.84 - $87.68 $789,019 - $1.1 Million	-12,556 Reduced 93.26%	907 $67,000
Q4 2020 Feb 09, 2021	BUY	$34.11 - $112.26 $211,652 - $696,573	6,205 Added 85.49%	13,463 $1.16 Million
Q3 2020 Nov 05, 2020	BUY	$29.36 - $47.1 $213,094 - $341,851	7,258 New	7,258 $274,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $57.5M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Alx Oncology Holdings Inc Transaction History